F8 and hemophilia A: In severe congenital hemophilia A patients with FVIII inhibitors, immune tolerance induction (ITI) therapy using regular applications of FVIII for a certain period is the only proven strategy for eradication of FVIII inhibitors and induction of FVIII-specific immune tolerance [17].